STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] DAVITA INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

DaVita Inc. (DVA)11/15/2025 at a reported price of $0. Following this transaction, he is shown as holding 411 shares directly and 13,028 shares indirectly through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998. The filing is reported as being made by one reporting person.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DESOER BARBARA J

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/15/2025 A 411 A $0 411 D
Common Stock 13,028 I Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 11/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DaVita (DVA) report in this Form 4?

The filing reports that director Marc J. Desoer acquired 411 shares of DaVita common stock on 11/15/2025 at a reported price of $0.

How many DaVita (DVA) shares does Marc J. Desoer own after this transaction?

After the reported transaction, Marc J. Desoer holds 411 shares directly and 13,028 shares indirectly through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998.

What is the relationship of the reporting person to DaVita (DVA)?

The reporting person, Marc J. Desoer, is identified as a Director of DaVita Inc.

On what date did the reported DaVita (DVA) insider transaction occur?

The earliest transaction date reported in the Form 4 is 11/15/2025.

Was the DaVita (DVA) Form 4 filed by one or multiple reporting persons?

The filing indicates it is a Form filed by One Reporting Person, not a joint or group filing.

How is the indirect ownership of DaVita (DVA) shares held by Marc J. Desoer structured?

The indirect ownership of 13,028 shares is held through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998.

Davita Inc

NYSE:DVA

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

8.23B
35.27M
49.99%
51.9%
9%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER